Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALV Autoliv	$112.42 -0.6%	$112.29	$75.49 ▼ $118.98	$8.63B	1.39	796,418 shs	648,041 shs
BNP Bonavista Energy Co. (BNP.TO)		C$0.00	C$0.05 ▼ C$0.86	C$11.91M	N/A	1.20 million shs	822,399 shs
CS Credit Suisse Group	$0.89	$0.89	$0.82 ▼ $6.36	$2.77B	1.27	37.84 million shs	N/A
TLX Telix Pharmaceuticals	$11.34 -3.7%	$15.59	$11.34 ▼ $30.36	$3.84B	N/A	64,757 shs	155,231 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALV Autoliv	0.00%	+1.96%	-4.74%	+14.67%	+18.79%
BNP Bonavista Energy Co. (BNP.TO)	0.00%	0.00%	0.00%	0.00%	0.00%
CS Credit Suisse Group	0.00%	0.00%	0.00%	0.00%	0.00%
TLX Telix Pharmaceuticals	0.00%	-13.10%	-29.57%	-33.99%	+1,133,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALV Autoliv	3.8867 of 5 stars	2.4	5.0	2.5	0.0	3.1	2.5	1.9
BNP Bonavista Energy Co. (BNP.TO)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CS Credit Suisse Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLX Telix Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALV Autoliv	2.84	Moderate Buy	$120.64	7.31% Upside
BNP Bonavista Energy Co. (BNP.TO)	0.00	N/A	N/A	N/A
CS Credit Suisse Group	0.00	N/A	N/A	N/A
TLX Telix Pharmaceuticals	3.00	Buy	$22.33	96.94% Upside

Current Analyst Ratings Breakdown

Latest CS, ALV, TLX, and BNP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/21/2025	ALV Autoliv	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$126.00 ➝ $124.00
7/16/2025	ALV Autoliv	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$105.00 ➝ $135.00
7/11/2025	ALV Autoliv	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$108.00 ➝ $126.00
7/9/2025	TLX Telix Pharmaceuticals	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
7/3/2025	TLX Telix Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$23.00
7/2/2025	ALV Autoliv	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$140.00
7/1/2025	ALV Autoliv	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$100.00 ➝ $104.00
6/25/2025	ALV Autoliv	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$133.00
6/12/2025	TLX Telix Pharmaceuticals	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$22.00
6/5/2025	TLX Telix Pharmaceuticals	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$22.00
5/28/2025	ALV Autoliv	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$103.00 ➝ $123.00

(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALV Autoliv	$10.39B	0.83	$13.58 per share	8.28	$32.29 per share	3.48
BNP Bonavista Energy Co. (BNP.TO)	C$313.05M	0.00	N/A	N/A	C$2.58 per share	0.00
CS Credit Suisse Group	$22.88B	0.12	$0.25 per share	3.51	$15.26 per share	0.06
TLX Telix Pharmaceuticals	$516.72M	7.43	$0.11 per share	99.31	$1.12 per share	10.13

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALV Autoliv	$647M	$9.14	12.30	10.38	1.17	6.83%	30.73%	8.86%	10/17/2025 (Estimated)
BNP Bonavista Energy Co. (BNP.TO)	N/A	-C$3.17	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CS Credit Suisse Group	-$7.64B	$0.65	1.37	∞	N/A	15.12%	23.83%	1.81%	N/A
TLX Telix Pharmaceuticals	$32.93M	N/A	0.00	23.63	N/A	N/A	N/A	N/A	8/20/2025 (Estimated)

Latest CS, ALV, TLX, and BNP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/20/2025	H1 2025	TLX Telix Pharmaceuticals	$0.2160	N/A	N/A	N/A	$316.69 million	N/A
7/18/2025	Q2 2025	ALV Autoliv	$2.07	$2.21	+$0.14	$2.16	$2.57 billion	$2.71 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALV Autoliv	$2.80	2.49%	N/A	30.63%	1 Years
BNP Bonavista Energy Co. (BNP.TO)	N/A	38.10%	N/A	N/A	N/A
CS Credit Suisse Group	$0.05	5.62%	N/A	7.69%	N/A
TLX Telix Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Latest CS, ALV, TLX, and BNP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/4/2025	ALV Autoliv	quarterly	$0.85	3.31%	9/5/2025	9/5/2025	9/23/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALV Autoliv	0.55	0.93	0.70
BNP Bonavista Energy Co. (BNP.TO)	119.59	0.07	0.04
CS Credit Suisse Group	2.79	1.53	1.53
TLX Telix Pharmaceuticals	0.99	2.78	2.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALV Autoliv	69.57%
BNP Bonavista Energy Co. (BNP.TO)	N/A
CS Credit Suisse Group	11.20%
TLX Telix Pharmaceuticals	N/A

Insider Ownership

Company	Insider Ownership
ALV Autoliv	0.20%
BNP Bonavista Energy Co. (BNP.TO)	N/A
CS Credit Suisse Group	N/A
TLX Telix Pharmaceuticals	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALV Autoliv	65,200	76.81 million	76.65 million	Optionable
BNP Bonavista Energy Co. (BNP.TO)	N/A	264.65 million	N/A	Not Optionable
CS Credit Suisse Group	50,480	3.11 billion	N/A	Optionable
TLX Telix Pharmaceuticals	N/A	338.40 million	N/A	N/A

CS, ALV, TLX, and BNP Headlines

Recent News About These Companies

INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Telix Pharmaceuticals Limited â€“ TLX

August 9 at 12:05 PM | globenewswire.com

Telix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens Berman

August 8 at 3:58 PM | globenewswire.com

Telix Pharmaceuticals (NASDAQ:TLX) Sees Large Volume Increase - Time to Buy?

August 7 at 2:46 PM | marketbeat.com

ABC Arbitrage SA Takes Position in Telix Pharmaceuticals Limited (NASDAQ:TLX)

August 7 at 7:33 AM | marketbeat.com

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - Here's Why

August 6, 2025 | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX

August 6, 2025 | prnewswire.com

Broker says Telix shares could surge 80% higher after selloff

August 5, 2025 | msn.com

Telix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens Berman

August 5, 2025 | globenewswire.com

Telix Pharmaceuticals (NASDAQ:TLX) Reaches New 52-Week Low - Should You Sell?

August 5, 2025 | marketbeat.com

TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law Firm

July 31, 2025 | businesswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX

July 31, 2025 | prnewswire.com

Telix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens Berman

July 31, 2025 | prnewswire.com

Telix Pharmaceuticals (NASDAQ:TLX) Reaches New 1-Year Low - Should You Sell?

July 30, 2025 | marketbeat.com

Telix H1 2025 Results: Investor Webcast Notification

July 29, 2025 | globenewswire.com

Telix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens Berman

July 29, 2025 | globenewswire.com

Telix Pharmaceuticals: Assessing The Market's Pullback On SEC Inquiry

July 29, 2025 | seekingalpha.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX

July 28, 2025 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX

July 27, 2025 | prnewswire.com

Telix Pharmaceuticals (NASDAQ:TLX) Sees Strong Trading Volume - What's Next?

July 25, 2025 | marketbeat.com

Telix Pharmaceuticals Limited (TLX) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 24, 2025 | tmcnet.com

Securities Fraud Investigation Into Telix Pharmaceuticals Limited (TLX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

July 24, 2025 | businesswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Golden Cross Alert: 3 Stocks With Serious Upside Potential
By Chris Markoch | July 31, 2025
View Golden Cross Alert: 3 Stocks With Serious Upside Potential
3 High-Risk, High-Reward Stocks With Explosive Upside
By Nathan Reiff | July 16, 2025
View 3 High-Risk, High-Reward Stocks With Explosive Upside
Palantir Bulls and Bears Set for an August Showdown
By Chris Markoch | July 22, 2025
View Palantir Bulls and Bears Set for an August Showdown
3 Bullish Biotech Stocks With Explosive Growth Trends
By Chris Markoch | July 21, 2025
View 3 Bullish Biotech Stocks With Explosive Growth Trends
CSX Stock Rally: Strong Options Flow, Analyst Price Targets
By Jeffrey Neal Johnson | July 18, 2025
View CSX Stock Rally: Strong Options Flow, Analyst Price Targets

CS, ALV, TLX, and BNP Company Descriptions

Autoliv NYSE:ALV

$112.42 -0.71 (-0.63%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$112.46 +0.04 (+0.04%)

As of 08/8/2025 06:27 PM Eastern

Autoliv, Inc., through its subsidiaries, develops, manufactures, and supplies passive safety systems to the automotive industry in Europe, the Americas, China, Japan, and rest of Asia. It offers passive safety systems, including modules and components for frontal-impact airbag protection systems, side-impact airbag protection systems, seatbelts, steering wheels, and inflator technologies. The company also provides mobility safety solutions, such as pedestrian protection, battery cut-off switches, connected safety services, and safety solutions for riders of powered two wheelers. It primarily serves car manufacturers. Autoliv, Inc. was founded in 1953 and is headquartered in Stockholm, Sweden.

Bonavista Energy Co. (BNP.TO) TSE:BNP

Bonavista Energy Corporation acquires, develops, and holds interests in oil and natural gas properties and assets in Western Canada. The company was founded in 1987 and is headquartered in Calgary, Canada.

Credit Suisse Group NYSE:CS

$0.89 0.00 (0.00%)

As of 06/13/2023

Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse's Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headqua

Telix Pharmaceuticals NASDAQ:TLX

$11.34 -0.44 (-3.74%)

Closing price 08/8/2025 04:00 PM Eastern

Extended Trading

$11.38 +0.04 (+0.35%)

As of 08/8/2025 07:54 PM Eastern

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time